{"name": "Ascletis",
 "permalink": "ascletis",
 "crunchbase_url": "http://www.crunchbase.com/company/ascletis",
 "homepage_url": "http://www.ascletis.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": null,
 "number_of_employees": null,
 "founded_year": 2011,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "bd@ascletis.com",
 "phone_number": "1-919-328-0212",
 "description": "",
 "created_at": "Thu Apr 07 03:38:22 UTC 2011",
 "updated_at": "Thu Apr 07 03:48:45 UTC 2011",
 "overview": "\u003Cp\u003EAscletis is a joint venture between U.S. and Chinese entrepreneurs aimed at building a global specialty therapeutics business dedicated to discovering and developing important new treatments for cancer and infectious diseases. Ascletis leverages U.S./European innovation and pharmaceutical/biotech strategic experience and China\u00e2\u20ac\u2122s capital efficiency with a goal of establishing in the near term a sustainable business and accelerated revenues through the in-licensing, late-stage clinical development, and commercialization of new medicines for the growing Chinese pharmaceutical marketplace. At the same time, the company is building long-term value through the discovery, demonstration of clinical proof-of-concept, and global partnering of novel therapeutics for life-threatening diseases.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       69],
      "assets/images/resized/0012/9559/129559v1-max-150x150.jpg"],
     [[166,
       77],
      "assets/images/resized/0012/9559/129559v1-max-250x250.jpg"],
     [[166,
       77],
      "assets/images/resized/0012/9559/129559v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$100M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.ascletis.com/n04062011.html",
    "source_description": "US-China Based Ascletis, Inc. Raises $100 Million from Private Chinese Investors for Specialty Therapeutics Venture",
    "raised_amount": 100000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 4,
    "funded_day": 6,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Hangzhou Binjiang Investment Holding",
         "permalink": "hangzhou-binjiang-investment-holding",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "1002 Northridge Lane",
    "address2": "",
    "zip_code": "27514",
    "city": "Chapel Hill",
    "state_code": "NC",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        93],
       "assets/images/resized/0012/9560/129560v1-max-150x150.jpg"],
      [[250,
        155],
       "assets/images/resized/0012/9560/129560v1-max-250x250.jpg"],
      [[450,
        280],
       "assets/images/resized/0012/9560/129560v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}